Press "Enter" to skip to content

Phase II Data Suggest Predictive Value of Preexisting CD8+ T Cells in SCLC – Targeted Oncology

admin 0

Phase II Data Suggest Predictive Value of Preexisting CD8+ T Cells in SCLC  Targeted Oncology

Findings from a phase II study in patients with small cell lung cancer suggested tumor immune phenotypes can be predictive of response to immune checkpoint …

“lung cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *